Ascendis

Business

Ascendis Pharma GAAP EPS of -€1.91, revenue of €36M; revises FY24 revenue outlook

Ascendis Pharma press release (ASND): Q2 GAAP EPS of -€1.91. Revenue of €36M (-24.0% Y/Y). SKYTROFA Q2 revenue of €26…

Read More »
Back to top button